| UniProt ID | CEP70_HUMAN | |
|---|---|---|
| UniProt AC | Q8NHQ1 | |
| Protein Name | Centrosomal protein of 70 kDa | |
| Gene Name | CEP70 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 597 | |
| Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Localized at the center of the radial microtubule array in interphase and at the spindle poles during various stages of mitosis. | |
| Protein Description | Plays a role in the organization of both preexisting and nascent microtubules in interphase cells. During mitosis, required for the organization and orientation of the mitotic spindle.. | |
| Protein Sequence | MFPVAPKPQDSSQPSDRLMTEKQQEEAEWESINVLLMMHGLKPLSLVKRTDLKDLIIFDKQSSQRMRQNLKLLVEETSCQQNMIQELIETNQQLRNELQLEQSRAANQEQRANDLEQIMESVKSKIGELEDESLSRACHQQNKIKDLQKEQKTLQVKCQHYKKKRTEQEETIASLQMEVCRLKKEEEDRIVTQNRVFAYLCKRVPHTVLDRQLLCLIDYYESKIRKIHTQRQYKEDESQSEEENDYRNLDASPTYKGLLMSLQNQLKESKSKIDALSSEKLNLQKDLETRPTQHELRLYKQQVKKLEKALKKNVKLQELINHKKAEDTEKKDEPSKYNQQQALIDQRYFQVLCSINSIIHNPRAPVIIYKQTKGGVQNFNKDLVQDCGFEHLVPVIEMWADQLTSLKDLYKSLKTLSAELVPWLNLKKQDENEGIKVEDLLFIVDTMLEEVENKEKDSNMPHFQTLQAIVSHFQKLFDVPSLNGVYPRMNEVYTRLGEMNNAVRNLQELLELDSSSSLCVLVSTVGKLCRLINEDVNEQVMQVLGPEDLQSIIYKLEEHEEFFPAFQAFTNDLLEILEIDDLDAIVPAVKKLKVLSY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 45 | Phosphorylation | MHGLKPLSLVKRTDL HCCCCCHHHCCCCCC | 39.38 | 24719451 | |
| 53 | Ubiquitination | LVKRTDLKDLIIFDK HCCCCCCCHHEEECH | 53.98 | - | |
| 60 | Ubiquitination | KDLIIFDKQSSQRMR CHHEEECHHHHHHHH | 41.13 | - | |
| 77 | Phosphorylation | LKLLVEETSCQQNMI HHHHHHHHHHHHHHH | 22.69 | 29978859 | |
| 78 | Phosphorylation | KLLVEETSCQQNMIQ HHHHHHHHHHHHHHH | 17.13 | 29978859 | |
| 90 | Phosphorylation | MIQELIETNQQLRNE HHHHHHHHHHHHHHH | 31.19 | 29978859 | |
| 121 | Phosphorylation | DLEQIMESVKSKIGE HHHHHHHHHHHHHHH | 19.91 | 26074081 | |
| 123 (in isoform 3) | Ubiquitination | - | 56.14 | 21906983 | |
| 123 (in isoform 2) | Ubiquitination | - | 56.14 | 21906983 | |
| 123 (in isoform 1) | Ubiquitination | - | 56.14 | 21906983 | |
| 123 | Ubiquitination | EQIMESVKSKIGELE HHHHHHHHHHHHHCC | 56.14 | 21906983 | |
| 124 | Phosphorylation | QIMESVKSKIGELED HHHHHHHHHHHHCCH | 27.61 | 24719451 | |
| 125 | Ubiquitination | IMESVKSKIGELEDE HHHHHHHHHHHCCHH | 49.35 | - | |
| 133 | Phosphorylation | IGELEDESLSRACHQ HHHCCHHHHHHHHHH | 43.92 | 28348404 | |
| 135 | Phosphorylation | ELEDESLSRACHQQN HCCHHHHHHHHHHHH | 27.41 | 24719451 | |
| 153 | Phosphorylation | DLQKEQKTLQVKCQH HHHHHHHHHHHHHHH | 23.32 | 23403867 | |
| 157 | Ubiquitination | EQKTLQVKCQHYKKK HHHHHHHHHHHHHCC | 18.40 | - | |
| 202 | Ubiquitination | RVFAYLCKRVPHTVL HHHHHHHCCCCCCHH | 54.56 | - | |
| 233 | Phosphorylation | KIHTQRQYKEDESQS HHHHHHCHHCCCCCC | 20.66 | 28634120 | |
| 238 | Phosphorylation | RQYKEDESQSEEEND HCHHCCCCCCHHHHC | 51.86 | 28985074 | |
| 240 | Phosphorylation | YKEDESQSEEENDYR HHCCCCCCHHHHCCC | 57.14 | 28985074 | |
| 246 | Phosphorylation | QSEEENDYRNLDASP CCHHHHCCCCCCCCH | 17.00 | 23090842 | |
| 252 | Phosphorylation | DYRNLDASPTYKGLL CCCCCCCCHHHHHHH | 19.90 | 28985074 | |
| 256 | Ubiquitination | LDASPTYKGLLMSLQ CCCCHHHHHHHHHHH | 45.63 | - | |
| 267 | Ubiquitination | MSLQNQLKESKSKID HHHHHHHHHCHHHHH | 50.61 | - | |
| 271 | Phosphorylation | NQLKESKSKIDALSS HHHHHCHHHHHHHHH | 44.09 | 24719451 | |
| 272 | Ubiquitination | QLKESKSKIDALSSE HHHHCHHHHHHHHHH | 48.63 | - | |
| 277 | Phosphorylation | KSKIDALSSEKLNLQ HHHHHHHHHHHHCCC | 37.87 | 30622161 | |
| 278 | Phosphorylation | SKIDALSSEKLNLQK HHHHHHHHHHHCCCH | 39.33 | 30622161 | |
| 280 | Ubiquitination | IDALSSEKLNLQKDL HHHHHHHHHCCCHHH | 44.62 | - | |
| 285 | Ubiquitination | SEKLNLQKDLETRPT HHHHCCCHHHCCCCC | 68.40 | - | |
| 300 | Ubiquitination | QHELRLYKQQVKKLE HHHHHHHHHHHHHHH | 38.55 | - | |
| 315 | Ubiquitination | KALKKNVKLQELINH HHHHHCCCHHHHHHC | 54.57 | - | |
| 323 | Ubiquitination | LQELINHKKAEDTEK HHHHHHCCCHHHCCC | 49.55 | - | |
| 324 | Ubiquitination | QELINHKKAEDTEKK HHHHHCCCHHHCCCC | 49.83 | - | |
| 336 | Ubiquitination | EKKDEPSKYNQQQAL CCCCCCCHHHHHHHH | 59.96 | - | |
| 357 | Phosphorylation | QVLCSINSIIHNPRA HHHHHHHHHHCCCCC | 22.65 | 30631047 | |
| 370 | Ubiquitination | RAPVIIYKQTKGGVQ CCCEEEEECCCCCCC | 40.87 | - | |
| 370 (in isoform 2) | Ubiquitination | - | 40.87 | - | |
| 373 | Ubiquitination | VIIYKQTKGGVQNFN EEEEECCCCCCCCCC | 51.69 | - | |
| 427 | Ubiquitination | LVPWLNLKKQDENEG HHHHHCCCCCCCCCC | 47.52 | 2190698 | |
| 427 (in isoform 1) | Ubiquitination | - | 47.52 | 21906983 | |
| 427 (in isoform 2) | Ubiquitination | - | 47.52 | 21906983 | |
| 428 | Ubiquitination | VPWLNLKKQDENEGI HHHHCCCCCCCCCCC | 67.17 | - | |
| 471 | Phosphorylation | QTLQAIVSHFQKLFD HHHHHHHHHHHHHHC | 16.69 | 29391485 | |
| 493 | Phosphorylation | YPRMNEVYTRLGEMN CCHHHHHHHHHHHHH | 4.67 | 22210691 | |
| 494 | Phosphorylation | PRMNEVYTRLGEMNN CHHHHHHHHHHHHHH | 25.29 | 22210691 | |
| 593 | Ubiquitination | VPAVKKLKVLSY--- HHHHHHCCCCCC--- | 50.43 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CEP70_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CEP70_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CEP70_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...